NCT06242366 Transitional Care Program in Stroke Patients With Hemiplegia.
| NCT ID | NCT06242366 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mahidol University |
| Condition | Ischemic Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-02-07 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-02-07 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines the effects of a transitional care program in stroke patients on self-care behavior, quality of life, and hospital readmission. The research conceptual framework is based on the Transitional Care Model by Naylor. Sixty participants with stroke patients at Charoenkrung Pracharak Hospital will be recruited. These participants are stratified by block randomization using NIHSS score and divided into 2 groups; a control group (n=30) and an intervention group (n=30). The program consisted of 2 phases: 1) Phase I during hospital admission and 2) Phase II following hospital discharge
Eligibility Criteria
Inclusion Criteria: * Age from 18 years old. * The first diagnosis is acute ischemic stroke. * Hemiplegia * NIHSS 5-14 point (moderate impairment) * Telephone and Line Application used. * Can read and communicate in Thai language * Accept participants to research and inform consent. Exclusion Criteria: * Aphasia * The Six Item Cognitive Impairment Test: 6CIT from 8 points in age from 60 years old. * Participants with illness severity or dead during the study. * Reject the study
Contact & Investigator
Rungnapa Premkamol
PRINCIPAL INVESTIGATOR
Mahidol University
Frequently Asked Questions
Who can join the NCT06242366 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06242366 currently recruiting?
Yes, NCT06242366 is actively recruiting participants. Contact the research team at rungnapa.pre@student.mahidol.ac.th for enrollment information.
Where is the NCT06242366 trial being conducted?
This trial is being conducted at Bang Kho Laem, Thailand.
Who is sponsoring the NCT06242366 clinical trial?
NCT06242366 is sponsored by Mahidol University. The principal investigator is Rungnapa Premkamol at Mahidol University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.